{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:58:24Z","timestamp":1715993904005},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1186\/1745-6215-7-33","type":"journal-article","created":{"date-parts":[[2006,12,19]],"date-time":"2006-12-19T19:14:26Z","timestamp":1166555666000},"source":"Crossref","is-referenced-by-count":15,"title":["Fracture risk and the use of a diuretic (indapamide sr) \u00b1 perindopril: a substudy of the Hypertension in the Very Elderly Trial (HYVET)"],"prefix":"10.1186","volume":"7","author":[{"given":"Christopher J","family":"Bulpitt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan A","family":"Staessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutgarde","family":"Thijs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Christine","family":"De Vernejoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid E","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel S","family":"Beckett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,12,19]]},"reference":[{"key":"170_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1046\/j.1523-1755.1998.00779.x","volume":"53","author":"LJ Melton","year":"1998","unstructured":"Melton LJ, Crowson CS, Khosla S, Wilson DM, O'Fallon WM: Fracture risk among patients with urolithiasis: a population based cohort study. Kidney Int. 1998, 53: 459-464. 10.1046\/j.1523-1755.1998.00779.x.","journal-title":"Kidney Int"},{"key":"170_CR2","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/0026-0495(79)90139-2","volume":"28","author":"S Lawoyin","year":"1979","unstructured":"Lawoyin S, Sismilich S, Browne R, Pak CY: Bone mineral content in patients with calcium urolithiasis. Metabolism. 1979, 28: 1250-1254. 10.1016\/0026-0495(79)90139-2.","journal-title":"Metabolism"},{"key":"170_CR3","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1210\/jcem-50-4-654","volume":"50","author":"HH Malluche","year":"1980","unstructured":"Malluche HH, Tschoepe W, Ritz E, Meyer-Sabellek W, Massry SG: Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab. 1980, 50: 654-8.","journal-title":"J Clin Endocrinol Metab"},{"key":"170_CR4","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1136\/bmj.300.6734.1234","volume":"300","author":"FP Cappuccio","year":"1990","unstructured":"Cappuccio FP, Strazzullo P, Mancini M: Kidney stones and hypertension: population based study of an independent clinical association. BMJ. 1990, 300: 1234-6.","journal-title":"BMJ"},{"key":"170_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-642-72370-4_5","volume":"22","author":"WG Robertson","year":"1984","unstructured":"Robertson WG, Peacock M, Baker M: Epidemiological studies on urinary stone disease in men in Leeds. Fortsch Urol Nephrol. 1984, 22: 27-32.","journal-title":"Fortsch Urol Nephrol"},{"key":"170_CR6","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1172\/JCI24134","volume":"115","author":"T Nijenhuis","year":"2005","unstructured":"Nijenhuis T, Vallon V, van der Kemp AW, Loffing J, Hoenderop JG, Bindels RJ: Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest. 2005, 115: 1651-8. 10.1172\/JCI24134.","journal-title":"J Clin Invest"},{"key":"170_CR7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0022-5347(17)53269-3","volume":"128","author":"D Scholz","year":"1982","unstructured":"Scholz D, Schwille PO, Sigel A: Double-blind study with thiazide in recurrent calcium lithiasis. J Urol. 1982, 128: 903-7.","journal-title":"J Urol"},{"key":"170_CR8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1046\/j.1523-1755.2003.00128.x","volume":"64","author":"T Nijenhuis","year":"2003","unstructured":"Nijenhuis T, Hoenderop JG, Loffing J, van der Kemp AW, van Os CH, Bindels RJ: Thiazide-induced hypocalciuria is accompanied by a decreased expression of Ca2+ transport proteins in kidney. Kidney Int. 2003, 64: 555-64. 10.1046\/j.1523-1755.2003.00128.x.","journal-title":"Kidney Int"},{"key":"170_CR9","first-page":"383","volume":"215","author":"E Laerum","year":"1984","unstructured":"Laerum E, Larsen S: Thiazide prophylaxis of urolithiasis. Arch Med Scand. 1984, 215: 383-9.","journal-title":"Arch Med Scand"},{"key":"170_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/978-1-4684-7272-1_115","volume-title":"Urolithiasis and related clinical research","author":"WG Robertson","year":"1985","unstructured":"Robertson WG, Peacock M, Selby PL, Williams RE, Clark P, Chisholm GD, Hargreaves TB, Rose MB, Wilkinson H: A multicentre trial to evaluate three treatments for recurrent idiopathic calcium stone disease \u2013 a preliminary report. Urolithiasis and related clinical research. Edited by: Schwille PO, Smith LH, Robertson WG, Vahlensieck W. 1985, New York: Plenum Press, 545-8."},{"key":"170_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/978-1-4684-7272-1_116","volume-title":"Urolithiasis and related clinical research","author":"B Ettinger","year":"1985","unstructured":"Ettinger B, Citron JT, Tang A, Livermore B: Prophylaxis of calcium oxalate stones:clinical trials of allopurinol magnesium hydroxide and chlorthalidone. Urolithiasis and related clinical research. Edited by: Schwille PO, Smith LH, Robertson WG, Vahlensieck W. 1985, New york: Plenum Press, 549-52."},{"key":"170_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(81)90302-0","volume":"2","author":"P Brocks","year":"1981","unstructured":"Brocks P, Dahl C, Wolf H, Transnbol I: Do thiazides prevent recurrent idiopathic renal calcium stones?. Lancet. 1981, 2: 124-5. 10.1016\/S0140-6736(81)90302-0.","journal-title":"Lancet"},{"key":"170_CR13","first-page":"119","volume":"135","author":"G Lemieux","year":"1986","unstructured":"Lemieux G: Treatment of idiopathic hypercalciuria with indapamide. CMAJ. 1986, 135: 119-21.","journal-title":"CMAJ"},{"key":"170_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1159\/000138405","volume":"36","author":"L Borghi","year":"1988","unstructured":"Borghi L, Elia G, Trapassi MR, Melloni E, Amato F, Barbarese F, Novarini A: Acute effect of indapamide on urine calcium excretion in nephrolithiasis and human essential hypertension. Pharmacology. 1988, 36: 348-55.","journal-title":"Pharmacology"},{"issue":"Suppl 6","key":"170_CR15","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1097\/00005344-199312050-00014","volume":"22","author":"L Borghi","year":"1993","unstructured":"Borghi L, Meschi T, Guerra A, Novarini A: Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol. 1993, 22 (Suppl 6): S78-86.","journal-title":"J Cardiovasc Pharmacol"},{"key":"170_CR16","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1345\/aph.1E544","volume":"39","author":"K Ceylan","year":"2005","unstructured":"Ceylan K, Topal C, Erkoc R, Sayarlioglu H, Can S, Yilmaz Y, Dogan E, Algun E, Gonulalan H: Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease. Ann Pharmacother. 2005, 39: 1034-8. 10.1345\/aph.1E544.","journal-title":"Ann Pharmacother"},{"key":"170_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1365-2125.1984.tb02458.x","volume":"18","author":"H Danielson","year":"1984","unstructured":"Danielson H, Pedersen EB, Spencer ED: Effect of indapamide on the renin-aldosterone system, and urinary excretion of potassium and calcium in essential hypertension. Br J Clin Pharmacol. 1984, 18: 229-31.","journal-title":"Br J Clin Pharmacol"},{"key":"170_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1359\/jbmr.2001.16.2.361","volume":"16","author":"A Lalande","year":"2001","unstructured":"Lalande A, Roux S, Denne MA, Stanley ER, Schiavi P, Guez D, De Vernejoul MC: Indapamide, a thiazide-like diuretic, decreases bone resorption in vitro. J Bone Miner Res. 2001, 16: 361-70. 10.1359\/jbmr.2001.16.2.361.","journal-title":"J Bone Miner Res"},{"key":"170_CR19","doi-asserted-by":"publisher","first-page":"516","DOI":"10.7326\/0003-4819-133-7-200010030-00010","volume":"133","author":"AZ LaCroix","year":"2000","unstructured":"LaCroix AZ, Ott SM, Ichikawa L, Scholes D, Barlow WE: Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized double-blind, placebo-controlled trial. Ann Intern Med. 2000, 133: 516-526.","journal-title":"Ann Intern Med"},{"key":"170_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0002-9343(00)00510-6","volume":"109","author":"IR Reid","year":"2000","unstructured":"Reid IR, Ames RW, Orr-Walker BJ, Clearwater JM, Horne Am, Evans MC, Murray MAF, McNeil AR, Gamble GD: Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomised controlled trial. Am J Med. 2000, 109: 362-370. 10.1016\/S0002-9343(00)00510-6.","journal-title":"Am J Med"},{"key":"170_CR21","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/jama.292.11.1326","volume":"292","author":"KG Schlienger","year":"2004","unstructured":"Schlienger KG, Kraenzlin ME, Jick SS, Meier CR: Use of beta-blockers and risk of fractures. JAMA. 2004, 292: 1326-32. 10.1001\/jama.292.11.1326.","journal-title":"JAMA"},{"key":"170_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00223-004-0084-2","volume":"76","author":"L Rejnmark","year":"2005","unstructured":"Rejnmark L, Vestergaard P, Mosckilde L: Reduced fractures risk in users of thiazide diuretics. Calif Tissue Int. 2005, 76: 167-75. 10.1007\/s00223-004-0084-2.","journal-title":"Calif Tissue Int"},{"key":"170_CR23","doi-asserted-by":"crossref","unstructured":"Schoofs MW, van der Klift M, Hofman A, de Laet CE, Herings RM, Stijnen T, Pols HA, Stricker BH: Thiazide diuretics and the risk for hip fracture. Ann Intern Med. 139 (6): 476-82. 2003 Sep 16","DOI":"10.7326\/0003-4819-139-6-200309160-00010"},{"key":"170_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF01623465","volume":"7","author":"D Feskannich","year":"1997","unstructured":"Feskannich D, Willett WC, Stampfer MJ, Colditz GA: A prospective study of thiazide use and fractures in women. Osteoporos Int. 1997, 7: 79-84. 10.1007\/BF01623465.","journal-title":"Osteoporos Int"},{"key":"170_CR25","first-page":"1525","volume":"12","author":"JA Cauley","year":"2055","unstructured":"Cauley JA, Fullman RL, Stone KL, Zmuda JM, Bauer DC, Barrett-Connor E, Ensrud K, Lau EM, Orwell ES, for the Mr. OS Research Group: Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int. 2055, 12: 1525-37.","journal-title":"Osteoporos Int"},{"key":"170_CR26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jbmr.5650100115","volume":"10","author":"G Jones","year":"1995","unstructured":"Jones G, Nguyen T, Sambrook PN, Eisman JA: Thiazide diuretics and fractures: can meta-analysis help?. J Bone Miner Res. 1995, 10: 106-111.","journal-title":"J Bone Miner Res"},{"key":"170_CR27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/08037050310001084","volume":"12","author":"F Timio","year":"2003","unstructured":"Timio F, Kerry SM, Anson KM, Eastwood JB, Cappucio FP: Calcium urolithiasis blood pressure and salt intake. Blood Press. 2003, 12: 122-7. 10.1080\/08037050310001084.","journal-title":"Blood Press"},{"key":"170_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2165\/00002512-200118030-00001","volume":"18","author":"CJ Bulpitt","year":"2001","unstructured":"Bulpitt CJ, Fletcher AE, Beckett N, Coope J, Gil-Extremera B, Forette F, Nachev C, Potter J, Sever P, Staessen J, Swift C, Tuomilehto J: Hypertension in the Very Elderly Trial (HYVET) Protocol for main trial. Drugs Aging. 2001, 18: 151-164. 10.2165\/00002512-200118030-00001.","journal-title":"Drugs Aging"},{"key":"170_CR29","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/gerona\/60.5.622","volume":"60","author":"F Landi","year":"2005","unstructured":"Landi F, Onder G, Cesari M, Barillaro C, Russo A, Bernabei R: Silver Network Home Care Study Group. Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci. 2005, 60: 622-6.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"170_CR30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/BF03324551","volume":"16","author":"K Kallin","year":"2004","unstructured":"Kallin K, Gustafson Y, Sandman PO, Karlsson S: Drugs and Falls in older people in geriatric care settings. Aging Clin Exp Res. 2004, 16: 270-6.","journal-title":"Aging Clin Exp Res"},{"key":"170_CR31","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.amjmed.2005.07.033","volume":"118","author":"M Kinjo","year":"2005","unstructured":"Kinjo M, Setoguchi S, Schneeweiss S, Soloman DH: Bone mineral density in subjects using central nervous system-active medications. Am J Med. 2005, 118: 1414-10.1016\/j.amjmed.2005.07.033.","journal-title":"Am J Med"},{"key":"170_CR32","doi-asserted-by":"publisher","first-page":"71el","DOI":"10.1016\/j.amjmed.2005.09.026","volume":"119","author":"B Renneboog","year":"2006","unstructured":"Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G: Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 2006, 119: 71el-8. 10.1016\/j.amjmed.2005.09.026.","journal-title":"Am J Med"},{"key":"170_CR33","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/ageing\/afi039","volume":"35","author":"G Rait","year":"2005","unstructured":"Rait G, Fletcher A, Smeeth L, Brayne C, Stirling S, Nunes M, Breeze E, Siu-Woon Ng E, Bulpitt CJ, Jones D, Tulloch AJ: Prevalence of cognitive impairment: results from the MRC trial of assessment and management of older people in the community. Age and Ageing. 2005, 35: 242-248. 10.1093\/ageing\/afi039.","journal-title":"Age and Ageing"},{"key":"170_CR34","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1176\/ajp.140.6.734","volume":"140","author":"R Katzman","year":"1983","unstructured":"Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H: Validation of a short orientation-memory-concentration test of cognitive impairment. American Journal Psychiatry. 1983, 140: 734-738.","journal-title":"American Journal Psychiatry"},{"key":"170_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"W Folstein","year":"1975","unstructured":"Folstein W, Folstein SE, Mc Hugh RP, \"Mini Mental State\": A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975, 12: 189-198. 10.1016\/0022-3956(75)90026-6.","journal-title":"Journal of Psychiatric Research"},{"key":"170_CR36","volume-title":"A Compendium of Neuropsychological Tests: Administration, Norms and Commentary","author":"O Spreen","year":"1998","unstructured":"Spreen O, Strauss E: A Compendium of Neuropsychological Tests: Administration, Norms and Commentary. 1998, Oxford: Oxford University Press, 2","edition":"2"},{"key":"170_CR37","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8","volume":"14","author":"O Almeida","year":"1999","unstructured":"Almeida O, Almeida S: Short versions of the Geriatric Depression Scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. International Journal of Geriatric Psychiatry. 1999, 14: 858-865. 10.1002\/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8.","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"170_CR38","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00198-005-2031-0","volume":"16","author":"M Maravic","year":"2005","unstructured":"Maravic M, Le Bihan C, Landais P, Fardellone P: Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database. Osteoporos Int. 2005, 16: 1475-1480. 10.1007\/s00198-005-2031-0.","journal-title":"Osteoporos Int"},{"key":"170_CR39","first-page":"195","volume-title":"Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study Bone","author":"SC Schuit","year":"2004","unstructured":"Schuit SC, van der Klift M, Weel AE, de Laet CE, Burger H, Seeman E, Hofman A, Uitterlinden AG, van Leeuwen JP, Pols HA: Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study Bone. 2004, 34 (1): 195-202."},{"key":"170_CR40","first-page":"1","volume":"12","author":"IM Giverson","year":"2006","unstructured":"Giverson IM: Time trends of age-adjusted incidence rates of first hip fractures: a register-based study among older people in Viborg County, Denmark, 1987\u20131997. Osteoporos Int. 2006, 12: 1-13.","journal-title":"Osteoporos Int"},{"key":"170_CR41","first-page":"708","volume":"7","author":"Y Leil","year":"2005","unstructured":"Leil Y, Castel H, Alkalay D: Marked secular increase in the incidence rates of osteoporotic hip fractures in women and men in southern Israel. Isr Med Assoc J. 2005, 7: 708-11.","journal-title":"Isr Med Assoc J"},{"key":"170_CR42","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1097\/00004872-200312000-00030","volume":"21","author":"CJ Bulpitt","year":"2003","unstructured":"Bulpitt CJ, Beckett NS, Cooke J, Dumitrascu DL, Gil-Extremera B, Nachev C, Nunes M, Peters R, Staessen JA, Thijs L, on behalf of the Hypertension in the Very Elderly Trial (HYVET) Working Group: Orthostatic fall in blood pressure in the very elderly hypertensive: results from the Hypertension in the Very Elderly Trial (HYVET) \u2013 Pilot. Trial J Hypertens. 2003, 21: 2409-2417. 10.1097\/00004872-200312000-00030.","journal-title":"Trial J Hypertens"},{"key":"170_CR43","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0140-6736(98)08127-6","volume":"353","author":"F Gueyffier","year":"1999","unstructured":"Gueyffier F, Bulpitt C, Boissel JP, Schron E, Ekbom T, Fagard R, Casiglia E, Kerlikoske K, Coope J: Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet. 1999, 353: 793-6. 10.1016\/S0140-6736(98)08127-6.","journal-title":"Lancet"},{"key":"170_CR44","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1359\/jbmr.1998.13.9.1444","volume":"13","author":"A Lalande","year":"1998","unstructured":"Lalande A, Roux C, Graulet AM, Schiavi P, De Vernejoul MC: The diuretic indapamide increases bone mass and decreases bone resorption in spontaneously hypertensive rats supplemented with sodium. J Bone Miner Res. 1998, 13: 1444-10.1359\/jbmr.1998.13.9.1444.","journal-title":"J Bone Miner Res"},{"key":"170_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-115-1-1","volume":"115","author":"FE Heidrich","year":"1991","unstructured":"Heidrich FE, Stergachis A, Gross KM: Diuretic drug use and the risk for hip fracture. Ann Intern Med. 1991, 115: 1-6.","journal-title":"Ann Intern Med"},{"key":"170_CR46","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","volume":"24","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L: Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens. 2006, 24: 581-589. 10.1097\/01.hjh.0000203845.26690.cb.","journal-title":"J Hypertens"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-7-33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-7-33\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-7-33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T13:17:01Z","timestamp":1707484621000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-7-33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["170"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-7-33","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]},"article-number":"33"}}